|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 746.00 USD | -1.05% |
|
-2.85% | -3.35% |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 14.34B | 31.41% | 34.05% | 16.13% | 12.48% | -1.09x | ||
| 9.09B | 20.13% | 25.95% | 14.03% | 6.99% | -0x | ||
| 3.95B | 31.29% | 39.94% | 17.59% | 11.33% | -0.18x | ||
| 15.56B | 19.3% | 28.72% | 16.36% | 7.75% | 1.74x | ||
| 9.89B | 13.07% | 28.69% | 7.39% | 4.5% | 0.68x | ||
| 1.94B | -145.16% | -158.13% | -28.87% | -21.31% | 2.03x | ||
| 5.14B | 25.03% | 31.43% | 31.7% | 22.02% | -1.81x | ||
| 3.06B | 1.69% | 28.34% | 14.97% | 0.67% | 0.88x | ||
| 502M | -144.39% | -104.25% | - | -78.14% | -2.48x | ||
| 150M | 66.87% | 49.52% | 39.67% | 25.58% | 1.24x | ||
| 3.22B | 10.83% | 12.71% | 5.94% | 4.79% | -1.97x | ||
| 638M | -28.69% | -26.12% | -252.11% | -29.11% | 0.85x | ||
| 389M | 52.64% | 41.45% | 18.91% | - | - | ||
| 308M | 4.73% | 4.18% | 0.85% | - | -5.29x | ||
| 8.83B | 5.34% | 18.49% | 6.14% | 2.42% | 4.83x | ||
| 417M | 20.18% | 20.74% | 5.55% | 5.17% | -1.12x | ||
| 3.57B | 7.74% | 8.68% | 6.46% | 4.03% | 3.63x | ||
| 1.05B | 21.46% | 26.05% | 4.9% | 5.4% | - | ||
| Average | 4.56B | 0.75% | 6.14% | -4.38% | -0.97% | 0.12x | |
| Weighted average by Cap. | 7.84B | 7.68% | 13.98% | 6.77% | 3.69% | 0.02x |
- Stock Market
- Equities
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
















